SCHEMBL854017

SCHEMBL854017

CCCCCNc1nc(C)c(Cc2cccc(OCCN(C)C)c2)c(N)n1

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DHFR P00374 10/20 0.62
TLR7 Q9NYK1 10/20 0.52
TLR8 Q9NR97 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853483 0.96 DHFR (0.62) DHFRTLR7
SCHEMBL854804 0.89 TLR7 (0.55) DHFRTLR7TLR8
SCHEMBL853209 0.86 DHFR (0.59) DHFRTLR7TLR8
SCHEMBL3707173 0.85 TLR7 (0.70) DHFRTLR7TLR8
SCHEMBL853213 0.85 TLR7 (0.57) DHFRTLR7TLR8
SCHEMBL854480 0.85 TLR7 (0.53) DHFRTLR7TLR8
SCHEMBL853780 0.84 DHFR (0.58) DHFRTLR7
SCHEMBL853997 0.83 TLR7 (0.52) DHFRTLR7TLR8
SCHEMBL861371 0.83 DHFR (0.57) DHFRTLR7
SCHEMBL19056429 0.83 DHFR (0.53) DHFRTLR7TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432768-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES AstraZeneca AB (SE) 2012-03-28 EP disclosed
WO-2010133885-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES ASTRAZENECA AB (SE) 2010-11-25 WO disclosed